tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CBAY

CymaBay Therapeutics: Major Acquisition and Leadership Overhaul
Company AnnouncementsCymaBay Therapeutics: Major Acquisition and Leadership Overhaul
12M ago
8K
CBAY
Gilead completes acquisition of CymaBay
PremiumThe Fly
Gilead completes acquisition of CymaBay
12M ago
CBAY
GILD
Gilead says CymaBay deal to lower 2024 EPS by $3.35-$3.45
PremiumThe Fly
Gilead says CymaBay deal to lower 2024 EPS by $3.35-$3.45
12M ago
CBAY
GILD
CymaBay Therapeutics Revamps Executive Compensation Agreements
PremiumCompany Announcements
CymaBay Therapeutics Revamps Executive Compensation Agreements
12M ago
8K
CBAY
CymaBay announces European Medicine accepts for review the MAA for seladelpar
PremiumThe Fly
CymaBay announces European Medicine accepts for review the MAA for seladelpar
12M ago
CBAY
Savara price target raised to $16 from $7 at Piper Sandler
PremiumThe FlySavara price target raised to $16 from $7 at Piper Sandler
12M ago
CBAY
SVRA
A New Cause for Concern: CymaBay Therapeutics Inc Adds a New Corporate Activity and Growth Risk
Premium
Company Announcements
A New Cause for Concern: CymaBay Therapeutics Inc Adds a New Corporate Activity and Growth Risk
1y ago
CBAY
CymaBay reports Q4 EPS (35c), consensus (31c)
Premium
The Fly
CymaBay reports Q4 EPS (35c), consensus (31c)
1y ago
CBAY
CymaBay’s seladelpar shows efficacy in Phase 3 study featured in NEJM
PremiumThe Fly
CymaBay’s seladelpar shows efficacy in Phase 3 study featured in NEJM
1y ago
CBAY
CymaBay downgraded to Market Perform from Outperform at Leerink
PremiumThe Fly
CymaBay downgraded to Market Perform from Outperform at Leerink
1y ago
CBAY
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
ACST
ADIL
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
CBAY
GERN
CymaBay downgraded to Market Perform from Outperform at LifeSci Capital
PremiumThe FlyCymaBay downgraded to Market Perform from Outperform at LifeSci Capital
1y ago
CBAY
CymaBay downgraded to Neutral from Buy at UBS
Premium
The Fly
CymaBay downgraded to Neutral from Buy at UBS
1y ago
CBAY
CymaBay downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
CymaBay downgraded to Neutral from Overweight at Piper Sandler
1y ago
CBAY
CymaBay downgraded to Neutral from Buy at BTIG
PremiumThe Fly
CymaBay downgraded to Neutral from Buy at BTIG
1y ago
CBAY
GILD
CymaBay downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
CymaBay downgraded to Neutral from Buy at H.C. Wainwright
1y ago
CBAY
GILD
CymaBay downgraded to Market Perform from Strong Buy at Raymond James
PremiumThe Fly
CymaBay downgraded to Market Perform from Strong Buy at Raymond James
1y ago
CBAY
CymaBay downgraded to Neutral from Buy at B. Riley
PremiumThe Fly
CymaBay downgraded to Neutral from Buy at B. Riley
1y ago
CBAY
CymaBay downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe FlyCymaBay downgraded to Neutral from Overweight at Cantor Fitzgerald
1y ago
CBAY
CymaBay downgraded to Hold from Buy at JonesResearch
Premium
The Fly
CymaBay downgraded to Hold from Buy at JonesResearch
1y ago
CBAY
Gilead acquisition of CymaBay makes sense, says Wells Fargo
Premium
The Fly
Gilead acquisition of CymaBay makes sense, says Wells Fargo
1y ago
CBAY
GILD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >